FLT3 and myeloproliferative disorder: On the contrary, injection or overexpression of Flt3-L or constitutively active Flt3 signalling leads to the expansion of the DC compartment and subsequently to a myeloproliferative disorder (MPD)15, 22, 29, 30, 31.